**Question:** Regarding dihydroaemisinin pharmacokinetics, all are true except:-

A. Dihydroaemisinin is rapidly absorbed and reaches peak plasma concentration within 2 hours of oral administration.
B. Dihydroaemisinin is extensively bound to plasma proteins, resulting in minimal free fraction.
C. Dihydroaemisinin undergoes extensive first-pass liver extraction, resulting in low bioavailability.
D. Dihydroaemisinin has a half-life of 2-3 hours, allowing for twice-daily dosing.

**Correct Answer:** D. Dihydroaemisinin has a half-life of 2-3 hours, allowing for twice-daily dosing.

**Core Concept:** Dihydroaemisinin is a pharmacokinetic parameter that describes how long it takes for the concentration of a drug to be reduced by half in the body. A shorter half-life indicates a drug with rapid clearance and may require more frequent dosing to maintain therapeutic levels.

**Why the Correct Answer is Right:** Dihydroaemisinin has a half-life of 2-3 hours, indicating a rapid clearance from the body. This results in a need for more frequent dosing, not allowing for twice-daily administration. In contrast, options A, B, and C imply slower clearance and longer half-life, which would allow for longer dosing intervals.

**Why Each Wrong Option is Incorrect:**

A. The rapid absorption and peak concentration within 2 hours suggest a short half-life. However, the correct answer (D) indicates a longer half-life, contradicting this option.

B. Dihydroaemisinin is extensively bound to plasma proteins, meaning that a significant portion of the drug is not available to exert its pharmacological effect. This indicates a longer half-life and allows for twice-daily dosing. However, option D contradicts this by mentioning a shorter half-life.

C. Dihydroaemisinin undergoes extensive first-pass liver extraction, which results in low bioavailability and requires higher doses to achieve therapeutic levels. This implies a longer half-life, but option D states a shorter half-life, making it incorrect.

**Clinical Pearls:**

1. Understanding pharmacokinetic parameters like half-life helps in determining dosing regimens and predicting drug interaction with other medications with similar pharmacokinetic characteristics.
2. A shorter half-life indicates a need for more frequent dosing, while a longer half-life allows for less frequent dosing.